-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MQGo0GE0LiR2nsZqz1DXd22nUZ3GS/fHfAewAVxQYls3NlYytpdIRZb4Uv15zT/W 1h5Bxf+zP3ovD2PYn7GBmQ== 0001104659-07-010949.txt : 20070214 0001104659-07-010949.hdr.sgml : 20070214 20070214124313 ACCESSION NUMBER: 0001104659-07-010949 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TERCICA INC CENTRAL INDEX KEY: 0001262175 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260042539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79780 FILM NUMBER: 07616816 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6506244900 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIMMUNE INC /DE CENTRAL INDEX KEY: 0000873591 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 521555759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 35 W WATKINS MILL RD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3014170770 MAIL ADDRESS: STREET 1: 35 W WATKINS MILL ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 SC 13G/A 1 a07-4554_1sc13ga.htm SC 13G/A

 

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

 

 

 

SCHEDULE 13G

 

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

TERCICA, INC.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

88078L 10 5

(CUSIP Number)

December 31, 2006

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.




 

 

 

1.

Names of Reporting Persons.
I.R.S. Identification Nos. of above persons

MedImmune, Inc. (EIN No. 52-1555759)

 

 

2.

Check the Appropriate Box if a Member of a Group

 

 

(a)

o

 

 

(b)

o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
2,996,250

 

6.

Shared Voting Power
0

 

7.

Sole Dispositive Power
2,996,250

 

8.

Shared Dispositive Power
0

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
2,996,250

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares   o

 

 

11.

Percent of Class Represented by Amount in Row (9)
5.98%

 

 

12.

Type of Reporting Person
CO

 

2




 

Item 1(a).

 

Name of Issuer:

 

 

 

 

 

Tercica, Inc.

 

 

 

Item 1(b).

 

Address of Issuer’s Principal Executive Offices:

 

 

 

 

 

2000 Sierra Point Parkway, Suite 400

 

 

Brisbane, CA 94005

 

 

 

Item 2(a).

 

Name of Person Filing:

 

 

 

 

 

MedImmune, Inc.

 

 

 

Item 2(b).

 

Address of Principal Business Office or, if none, Residence:

 

 

 

 

 

One MedImmune Way

 

 

Gaithersburg, MD 20878

 

 

 

Item 2(c).

 

Citizenship:

 

 

 

 

 

Delaware

 

 

 

Item 2(d).

 

Title of Class of Securities:

 

 

 

 

 

Common Stock

 

 

 

Item 2(e).

 

CUSIP Number

 

 

 

 

 

88078L 10 5

 

 

 

Item 3.

 

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

 

(a)

 

Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).

 

 

 

 

 

 

 

(b)

 

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

 

 

 

 

 

 

 

(c)

 

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)

 

 

 

 

 

 

 

(d)

 

Investment company registered under section 8 of the Investment Company Act of 1940

 

 

 

 

 (15 U.S.C. 80a-8)

 

 

 

 

 

 

 

(e)

 

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

 

 

 

 

 

 

 

(f)

 

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

 

 

 

 

 

 

 

(g)

 

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

 

 

 

 

 

 

 

(h)

 

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act

 

 

 

 

(12 U.S.C. 1813);

 

 

 

 

 

 

 

(i)

 

A church plan that is excluded from the definition of an investment company under

 

 

 

 

section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

 

 

 

 

 

 

 

(j)

 

Group, in accordance with §240.13d-1(b)(1)(ii)(J):

 

3




 

Item 4(a).

 

Amount Beneficially Owned:

 

 

 

 

 

 

 

2,996,250 shares

 

 

 

 

 

Item 4(b).

 

Percent of Class:

 

 

 

 

 

 

 

5.98%

 

 

 

 

 

Item 4(c).

 

Number of shares as to which such person has:

 

 

 

 

 

 

 

(i)

 

sole power to vote or to direct the vote

 

 

 

 

 

 

 

 

 

2,996,250

 

 

 

 

 

 

 

(ii)

 

shared power to vote or to direct the vote

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

 

 

(iii)

 

sole power to dispose or to direct the disposition of

 

 

 

 

 

 

 

 

 

2,996,250

 

 

 

 

 

 

 

(iv)

 

shared power to dispose or to direct the disposition of

 

 

 

 

 

 

 

 

 

0

 

 

 

 

 

Item 5.

 

Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.

 

 

 

 

 

Item 6.

 

Ownership of More than Five Percent on Behalf of Another Person:

 

 

 

 

 

 

 

Not applicable.

 

 

 

 

 

Item 7.

 

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

 

 

 

 

 

 

 

Not applicable.

 

 

 

 

 

Item 8.

 

Identification and Classification of Members of the Group:

 

 

 

 

 

 

 

Not applicable.

 

 

 

 

 

Item 9.

 

Notice of Dissolution of Group:

 

 

 

 

 

 

 

Not applicable.

 

 

 

 

 

Item 10.

 

Certification:

 

 

 

 

 

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

4




SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2007

 

By:

 

/s/ Atul Saran

 

 

Name:

 

Atul Saran

 

 

Title:

 

Assistant Secretary

 

5



-----END PRIVACY-ENHANCED MESSAGE-----